| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 8,428,210 | 7,726,030 | 7,890,710 | 9,701,580 | 9,097,810 |
| Sales Growth | +9.09% | -2.09% | -18.67% | +6.64% | +22.99% |
| Net Income | 2,907,880 | 2,556,290 | 2,310,850 | 2,883,100 | 2,757,250 |
| Net Income Growth | +13.75% | +10.62% | -19.85% | +4.56% | +36.60% |
Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.
Fiscal Year End Date: 12/31